Q4 2024 Results Conference Call March 10, 2025 4:30 PM ETCompany ParticipantsJustin Schreiber - Chairman and Chief ...

Tenon Medical received notice of two approvals from the European patent office. The medical-device maker after the bell said two additional patents related to its Catamaran Sacroiliac Joint Fixation ...

NEW YORK, March 10, 2025 (GLOBE NEWSWIRE) -- Prospect Capital Management L.P. ("Prospect”), investment adviser to Prospect Capital Corporation (NASDAQ: PSEC) and other funds, announced today that ...

LifeMD Inc (LFMD)公布2024年第四季度业绩强劲,每股收益 (EPS)达到$0.21,远超预期亏损$0.05。公司收入达到$64.3百万,超过预期的$57.66百万。财报公布后,LifeMD股价在盘后交易中上涨19.44%,收于$5.10。

LifeMD reported a fourth-quarter loss per share of 2 cents. Analysts were expecting a loss of 5 cents per share, according to FactSet. Revenue for the fourth quarter came in at $64.3 million. Analysts ...

LifeMD, Inc. (LFMD) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to loss of $0.12 per share a year ago. These figures are ...

Reports Q4 revenue $64.3M, consensus $57.4M. “LifeMD (LFMD) had a great fourth quarter. We not only achieved record quarterly revenue and ...

M.Optimize Your Investment Research with SparkEffectively assess a stock's risks and opportunities with a clear ...

Consolidated revenues increased 43% year-over-year to $64.3 million with telehealth revenue up 60%Adjusted EBITDA increased 78% to $9.0 millionTelehealth adjusted EBITDA increased 396% to $5.9 ...

纽约 - 虚拟初级保健服务提供商LifeMD, Inc. (NASDAQ: LFMD )股价上涨16%，此前该公司发布的第四季度财报超出分析师预期，并提供了强劲的2025年业绩指引。 公司报告调整后每股收益为$0.21，较分析师预期的-$0.05高出$0.26。季度营收达到$64.3 million，同比增长43%，超过市场普遍预期的$57.66 million。

Pre-earnings options volume in LifeMD (LFMD) is 5.6x normal with calls leading puts 22:1. Implied volatility suggests the market is anticipating a ...

Stocks extended last week's losses on Monday as concerns over the U.S. economy continue to weigh on the market. The Nasdaq ...